欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4048/002
药品名称Ezetimibe/Simvastatin Glenmark 10 mg/20 mg Tablets
活性成分
    • ezetimibe 10.0 mg
    • simvastatin 20.0 mg
剂型Tablet
上市许可持有人Glenmark Pharmaceuticals Europe Limited Laxmi House, 2B Draycott Avenue, Kenton, Harrow Middlesex, HA3 0BU, United Kingdom
参考成员国 - 产品名称Netherlands (NL)
Ezetimibe/Simvastatine Glenmark
互认成员国 - 产品名称
    • Germany (DE)
      Ezetimibe/Simvastatine Glenmark 10 mg/20 mg Tabletten
    • Spain (ES)
    • Norway (NO)
      Ezetimib/Simvastatin Glenmark
    • Czechia (CZ)
      Glezisim
    • Slovakia (SK)
      Glezisim 10 mg/ 20 mg tablety
许可日期2018/08/07
最近更新日期2023/10/04
药物ATC编码
    • C10BA02 simvastatin and ezetimibe
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase